How should Enterococcus isolated from urine be interpreted and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Enterococcus in Urine: Interpretation and Management

The critical first step is distinguishing true urinary tract infection from asymptomatic bacteriuria (colonization), as treatment is only indicated for symptomatic infection—not colonization—in most clinical scenarios 1, 2.

Key Clinical Decision Points

1. Assess for True Infection vs. Colonization

Do NOT treat enterococcal bacteriuria unless:

  • Patient has urinary symptoms (dysuria, urgency, frequency, suprapubic pain) 3
  • Patient has systemic signs of infection with no other source
  • Specific high-risk scenarios exist (see below)

Asymptomatic bacteriuria should NOT be treated in the vast majority of patients, including those with:

  • Indwelling catheters (short-term or long-term) 2
  • Diabetes
  • Elderly patients
  • Spinal cord injury 2

The only exceptions where screening and treating asymptomatic bacteriuria is recommended are:

  • Pregnant patients
  • Patients undergoing endoscopic urologic procedures with mucosal trauma 2

2. Clinical Significance of Colony Counts

Low colony counts (10,000-100,000 CFU/mL) can represent true infection 3. In a study of 208 patients with enterococcal counts between 10,000-100,000 CFU/mL:

  • 54% had true UTI when pyuria was present
  • Urgency (OR=7.1) and hospitalization (OR=4.4) were independent predictors of true infection
  • No differential cutoff could be determined within this range 3

Clinical interpretation should prioritize:

  • Presence of pyuria (leukocytes in urine)
  • Urinary symptoms (urgency, frequency, dysuria)
  • Patient hospitalization status
  • Absence of alternative explanations

3. Species Identification Matters for Treatment

Enterococcus faecalis:

  • More susceptible to antibiotics
  • Ampicillin is the drug of choice 1
  • Low resistance rates to aminopenicillins 4, 5

Enterococcus faecium:

  • Significantly more resistant
  • Often resistant to ampicillin, fluoroquinolones, and beta-lactams (approaching 100%) 5
  • 24-55% vancomycin-resistant (VRE) in recent studies 4, 5
  • Requires glycopeptides or alternative agents 4

4. Treatment Algorithm

For Uncomplicated UTI (Outpatient, Symptomatic):

If E. faecalis or susceptibility unknown:

  • First-line: Ampicillin or amoxicillin (500 mg PO every 8 hours) 1
  • Alternatives:
    • Nitrofurantoin (good in vitro activity against VRE) 1
    • Fosfomycin (FDA-approved for E. faecalis UTI) 1

If E. faecium or known resistant:

  • Nitrofurantoin
  • Fosfomycin 1
  • Linezolid (if severe and other options unavailable) 6

For Complicated UTI or Pyelonephritis:

Vancomycin-susceptible strains:

  • High-dose ampicillin (18-30 g IV daily) for ampicillin-susceptible strains 1
  • Vancomycin for ampicillin-resistant strains

Vancomycin-resistant Enterococcus (VRE):

  • Daptomycin 8-12 mg/kg IV daily (preferred for serious infections due to bactericidal activity) 1
  • Linezolid 600 mg IV/PO every 12 hours 1, 6
  • Tigecycline (NOT for bacteremia due to low serum levels; reserved for intra-abdominal infections) 1

Note: Tigecycline should NOT be used for VRE bacteremia despite in vitro activity 1.

5. Special Populations Requiring Anti-Enterococcal Coverage

Empiric anti-enterococcal therapy is recommended for 7:

  • Healthcare-associated infections
  • Postoperative infections
  • Patients previously treated with cephalosporins
  • Immunocompromised patients
  • Valvular heart disease or prosthetic intravascular materials
  • Liver transplant recipients with hepatobiliary infections

6. High-Dose Ampicillin for Resistant Strains in UTI

A critical nuance: High urinary concentrations of ampicillin may overcome ampicillin resistance in VRE urinary tract infections 1. One retrospective study showed:

  • 88.1% clinical eradication
  • 86% microbiological eradication
  • Using ampicillin for ampicillin-resistant VRE UTIs 1

This suggests ampicillin may still be effective for UTI even when reported as resistant, due to high urinary drug concentrations.

Common Pitfalls to Avoid

  1. Treating asymptomatic bacteriuria: This promotes resistance without clinical benefit 2
  2. Assuming all enterococci are E. faecalis: E. faecium has dramatically different resistance patterns 5
  3. Using tigecycline for bacteremia: Low serum levels make it ineffective despite in vitro activity 1
  4. Ignoring low colony counts: 10,000-100,000 CFU/mL with pyuria often represents true infection 3
  5. Automatic catheter-associated treatment: Remove catheter when possible rather than treating colonization 2, 6

Infection Control Considerations

When VRE is isolated 8:

  • Notify infection control immediately
  • Implement contact precautions
  • Confirm vancomycin resistance with repeat testing
  • Screen high-risk patients (ICU, oncology, transplant) for colonization
  • Strict hand hygiene compliance

References

3
Research

Clinical significance of bacteriuria with low colony counts of Enterococcus species.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2006

4
Research

[Enterococcal infections and their treatment options].

Klinicka mikrobiologie a infekcni lekarstvi, 2021

6
Research

Treatment of resistant enterococcal urinary tract infections.

Current infectious disease reports, 2010

Related Questions

When is treatment indicated for Enterococcus faecalis isolated from a urine specimen, and what are the recommended antimicrobial regimens?
How should an isolated Enterococcus faecalis in a urine culture be interpreted and managed?
Should a urine culture growing 10,000–25,000 CFU/mL Enterococcus faecalis be treated as a urinary tract infection, and what is the appropriate antimicrobial regimen?
In a male patient with a urine culture revealing 30,000 CFU/mL Enterococcus, does this require antimicrobial therapy?
Is 10,000-49,000 colony-forming units (CFU) of enterococcus on a urine culture considered a true urinary tract infection (UTI)?
What is the recommended first-line antibiotic for an uncomplicated purulent skin abscess in an adult without known drug allergies?
What is the recommended inpatient management for a newly diagnosed patient with severe pulmonary hypertension?
Is it safe to start modafinil for narcolepsy in a patient already taking lamotrigine, quetiapine (Seroquel), bupropion (Wellbutrin), and citalopram (Celexa)?
In a newly diagnosed patient with severe pulmonary hypertension who is hemodynamically stable and breathing room air, what is the appropriate initial management?
What is the most likely cause of early miscarriage in a patient with polycystic ovary syndrome and a male partner with low sperm motility, given a normal hysterosalpingogram?
In a 19-year-old patient with a low activated protein C level of 1.7 IU, which laboratory test should be ordered to confirm Factor V Leiden?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.